Degussa BioActives, one of the market leaders in sports nutrition ingredients, has launched a worldwide ad campaign featuring the high-profile brands Creapure, Leci-PS, Leci-Choline, Arthred and Cholestatin.
The campaign includes consecutive-page ads in North American and European business-to-business publications. Shortly these ads will also be launched in the Asian market. The first page is an illustrated teaser, followed on the second page by technical information and a call to action. The full-page, artist-created and airbrushed illustrations focus both on Degussa BioActives quality as well as customer benefits. The new, colorful and artistic ad style is designed to have an emotional, rather than technical, delivery.
"The new ads are a shift from traditional technical marketing to an exciting display of what we can do for our customers," said Wolfgang Schuett, Vice President of Marketing and Sales. "The worldwide campaign reinforces both our commitment and strategy to differentiate ourselves from the competition."
Degussa BioActives specializes in a wide range of health-promoting ingredients for the food and dietary supplement industry. Technical information on Degussa BioActives' full line of ingredients can be found on the web site at www.degussa-bioactives.com.
Degussa is an entirely newly-formed, multinational corporation with sales of EUR12.9 billion and a workforce of some 53,400. In fiscal 2001, the corporation generated operating profits (EBITA) of more than EUR1 billion. Degussa's core strength lies in highly-effective system solutions tailored to the requirements of its customers in over 100 countries throughout the world. Its activities are led by the vision "Everybody benefits from a Degussa product – every day and everywhere".
This press release mentions filed and/or registered trademarks of Degussa BioActives. However, the absence of an according designation by ® or ™ should not be regarded as affecting the legal status of any of those trademarks and can not be interpreted as non-existing trademark rights.